These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35381761)

  • 1. Tumor infiltrating lymphocytes in head and neck squamous cell carcinoma - Evaluation and clinical impact.
    Dasgupta S; Chakrabarti S; Deb AR
    J Cancer Res Ther; 2022; 18(1):49-54. PubMed ID: 35381761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there any correlation between tumor infiltrating lymphocytes and expression of EGFR in squamous cell carcinoma of head and neck? A retrospective observational study.
    Dasgupta S; Biswas N; Deb AR; Chakrabarti S
    Indian J Pathol Microbiol; 2022; 65(2):262-267. PubMed ID: 35435357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
    Ahuja S; Khan AA; Zaheer S; Ranga S
    Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy.
    Choi S; Hossain M; Lee H; Baek J; Park HS; Lim CL; Han D; Park T; Kim JH; Gong G; Kweon MN; Lee HJ
    Cancer Immunol Immunother; 2024 Apr; 73(6):101. PubMed ID: 38630265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head-Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy.
    Koukourakis IM; Gkegka AG; Xanthopoulou E; Nanos C; Giatromanolaki A; Koukourakis MI
    Curr Oncol; 2022 Jun; 29(6):4274-4284. PubMed ID: 35735451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
    Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
    Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
    Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
    Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment.
    Kim DH; Ahn JS; Kang M; Park G; Lim Y; Hwang S; Ock CY; Koh J; Chung EJ; Kwon SK; Jeon YK; Jung KC; Ahn SH; Keam B
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
    Ngamphaiboon N; Chureemas T; Siripoon T; Arsa L; Trachu N; Jiarpinitnun C; Pattaranutaporn P; Sirachainan E; Larbcharoensub N
    Med Oncol; 2019 Jan; 36(2):21. PubMed ID: 30666437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
    Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
    de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
    Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
    Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
    Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
    Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM
    Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Tumor Infiltrating Lymphocyte Density with Histopathological Parameters and Effect on Prognosis in Head and Neck Squamous Cell Cancers.
    Sari E; Tokat T; Tarhan O; Dag H; Yilmaz YZ; Yener HM
    Sisli Etfal Hastan Tip Bul; 2020; 54(4):438-443. PubMed ID: 33364884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment nutritional status, HPV infection, and tumor infiltrating lymphocyte as prognostic predictors in patients with head and neck squamous cell carcinoma after chemotherapy.
    Sutandyo N; Brahma B; Ifandriani R
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S177-S181. PubMed ID: 36510961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of CD45 transcriptional expression in head and neck cancer.
    Camacho M; Agüero A; Sumarroca A; López L; Pavón MÁ; Avilés-Jurado FX; García J; Quer M; León X
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):225-232. PubMed ID: 29177949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method.
    De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L
    Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
    Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
    Qureshi HA; Zhu X; Yang GH; Steadele M; Pierce RH; Futran ND; Lee SM; Méndez E; Houghton AM
    Oral Oncol; 2022 Apr; 127():105774. PubMed ID: 35219073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas.
    Sánchez-Canteli M; Juesas L; Garmendia I; Otero-Rosales M; Calvo A; Alvarez-Fernández M; Astudillo A; Montuenga LM; García-Pedrero JM; Rodrigo JP
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.